Quarterly ResultMay 15, 2026, 06:18 AM
Adia Nutrition Q1 Revenue $176K; Net Loss Widens to $162K
AI Summary
Adia Nutrition reported a significant increase in total revenue to $176,275 for Q1 2026, up from $71,764 in Q1 2025, driven by medical procedures and new sales of biologics. Despite this revenue growth and a higher gross profit of $67,577, the company's net loss widened to $162,525, compared to a $116,219 net loss in the prior year, primarily due to increased operating expenses. The company continues to operate with a going concern warning due to its accumulated deficit of $16.1 million.
Key Highlights
- Total revenue increased to $176,275 in Q1 2026, up from $71,764 in Q1 2025.
- Net loss widened to $162,525 in Q1 2026, compared to $116,219 in Q1 2025.
- Gross profit rose to $67,577 in Q1 2026 from $14,052 in Q1 2025.
- Sales of biologics generated $69,775 in Q1 2026, a new revenue stream.
- Medical procedures revenue increased to $104,850 from $70,700 year-over-year.
- Operating expenses significantly increased to $219,497 from $124,596.
- Accumulated deficit reached $16,136,007 as of March 31, 2026.
- Cash at end of Q1 2026 was $136,716, up from $79,392 at year-end 2025.
Price Impact
More from ADIA